{"id":556,"date":"2025-05-06T11:26:28","date_gmt":"2025-05-06T16:56:28","guid":{"rendered":"https:\/\/smardea.com\/?p=556"},"modified":"2025-05-06T11:26:30","modified_gmt":"2025-05-06T16:56:30","slug":"disorders-that-can-be-inherited-caused-by-abnormalities-in-dna","status":"publish","type":"post","link":"https:\/\/smardea.com\/?p=556","title":{"rendered":"Disorders that can be inherited caused by abnormalities in DNA."},"content":{"rendered":"\n

Cataloging every genetic disorder<\/strong> with detailed information is a monumental task, as over 10,000 genetic disorders have been identified in humans alone, with thousands more in animals. Many are rare, poorly understood, or lack comprehensive documentation. <\/p>\n\n\n\n

So<\/strong> What is Genetics?<\/strong><\/p>\n\n\n\n

Genetics<\/strong> is the branch of biology that studies genes, heredity, and genetic variation<\/strong> in living organisms. It explains how traits are passed from parents to offspring and how genetic mutations can lead to diseases.<\/p>\n\n\n\n

Key Concepts in Genetics:<\/strong><\/h3>\n\n\n\n

Mutation:<\/strong>\u00a0A change in DNA sequence that can cause disease. Providing exhaustive details for each would exceed practical response limits and result in an overwhelming volume of information. Instead, I will provide a structured overview of the major categories of genetic disorders, highlight key examples within each category with detailed explanations, and include a representative list of disorders. For animals, I\u2019ll summarize common genetic disorders with examples. This approach balances comprehensiveness with clarity.<\/p>\n\n\n\n

DNA (Deoxyribonucleic Acid):<\/strong>\u00a0The molecule that carries genetic instructions.<\/p>\n\n\n\n

Gene:<\/strong>\u00a0A segment of DNA that codes for a specific protein or function.<\/p>\n\n\n\n

Chromosome:<\/strong>\u00a0A packaged structure of DNA (humans have\u00a023 pairs<\/strong>).<\/p>\n\n\n\n

Genome:<\/strong>\u00a0The complete set of genetic material in an organism.<\/p>\n\n\n\n

How Do Genetic Diseases Occur?<\/strong><\/h3>\n\n\n\n

Genetic disorders are caused by abnormalities in DNA,<\/strong> ranging from single-gene mutations to chromosomal anomalies. They can be inherited or arise spontaneously and affect humans and animals. Below is a detailed overview of the main categories, key examples with in-depth information, and a broader list of disorders.<\/p>\n\n\n\n

Genetic diseases occur due to mutations<\/strong> in DNA that disrupt normal biological functions. These mutations can be:<\/p>\n\n\n\n

    \n
  1. Inherited<\/strong>\u00a0(passed from parents to children)<\/li>\n\n\n\n
  2. Acquired<\/strong>\u00a0(caused by environmental factors like radiation or chemicals)<\/li>\n<\/ol>\n\n\n\n

    Mechanisms of Genetic Diseases:<\/strong><\/h3>\n\n\n\n
    Type of Mutation<\/strong><\/th>Effect<\/strong><\/th>Example Disease<\/strong><\/th><\/tr><\/thead>
    Single-Gene (Mendelian)<\/strong><\/td>Mutation in one gene<\/td>Cystic Fibrosis, Sickle Cell Anemia<\/td><\/tr>
    Chromosomal Abnormalities<\/strong><\/td>Extra\/missing chromosomes<\/td>Down Syndrome (Trisomy 21)<\/td><\/tr>
    Multifactorial Disorders<\/strong><\/td>Genes + environment<\/td>Heart Disease, Diabetes<\/td><\/tr>
    Mitochondrial Mutations<\/strong><\/td>Defects in mitochondrial DNA<\/td>Leber\u2019s Hereditary Optic Neuropathy<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
    \n\n\n\n

    1. Single-Gene Disorders<\/h3>\n\n\n\n

    These result from mutations in a single gene, following Mendelian inheritance patterns (autosomal dominant, autosomal recessive, or X-linked). Approximately 7,000 single-gene disorders are known in humans.<\/p>\n\n\n\n

    Key Examples<\/h3>\n\n\n\n

    Cystic Fibrosis (Autosomal Recessive)<\/h4>\n\n\n\n
      \n
    • Cause<\/strong>: Mutations in the CFTR<\/strong> gene (most common: \u0394F508 deletion) on chromosome 7, impairing chloride ion transport.<\/li>\n\n\n\n
    • Symptoms<\/strong>: Chronic lung infections, pancreatic insufficiency, salty sweat, infertility in males.<\/li>\n\n\n\n
    • Prevalence<\/strong>: ~1 in 2,500 newborns (higher in Caucasian populations).<\/li>\n\n\n\n
    • Diagnosis<\/strong>: Sweat chloride test, genetic testing.<\/li>\n\n\n\n
    • Treatment<\/strong>:\n
        \n
      • CFTR modulators (e.g., ivacaftor, lumacaftor) for specific mutations.<\/li>\n\n\n\n
      • Airway clearance therapies, antibiotics, pancreatic enzyme supplements.<\/li>\n<\/ul>\n<\/li>\n\n\n\n
      • Prognosis<\/strong>: Median life expectancy ~50 years with modern treatments.<\/li>\n\n\n\n
      • Research<\/strong>: Gene therapy trials and CRISPR-based correction of CFTR mutations.<\/li>\n<\/ul>\n\n\n\n

        Huntington\u2019s Disease (Autosomal Dominant)<\/h4>\n\n\n\n
          \n
        • Cause<\/strong>: CAG trinucleotide repeat expansion in the HTT<\/strong> gene on chromosome 4, leading to toxic huntingtin protein accumulation.<\/li>\n\n\n\n
        • Symptoms<\/strong>: Progressive motor dysfunction (chorea), cognitive decline, psychiatric issues (e.g., depression).<\/li>\n\n\n\n
        • Prevalence<\/strong>: ~1 in 10,000\u201320,000 globally.<\/li>\n\n\n\n
        • Diagnosis<\/strong>: Genetic testing for CAG repeats (>36 repeats confirm diagnosis).<\/li>\n\n\n\n
        • Treatment<\/strong>: Symptomatic (e.g., tetrabenazine for chorea, antipsychotics). No cure.<\/li>\n\n\n\n
        • Prognosis<\/strong>: Fatal 10\u201320 years after symptom onset.<\/li>\n\n\n\n
        • Research<\/strong>: RNA-based therapies (e.g., antisense oligonucleotides) and gene silencing.<\/li>\n<\/ul>\n\n\n\n

          Hemophilia A (X-Linked Recessive)<\/h4>\n\n\n\n
            \n
          • Cause<\/strong>: Mutations in the F8<\/strong> gene on the X chromosome, reducing functional factor VIII (blood clotting protein).<\/li>\n\n\n\n
          • Symptoms<\/strong>: Severe bleeding (joints, muscles), easy bruising, prolonged bleeding after injury.<\/li>\n\n\n\n
          • Prevalence<\/strong>: ~1 in 5,000 male births.<\/li>\n\n\n\n
          • Diagnosis<\/strong>: Coagulation tests, genetic testing.<\/li>\n\n\n\n
          • Treatment<\/strong>:\n
              \n
            • Factor VIII replacement therapy (infusions).<\/li>\n\n\n\n
            • Gene therapy (e.g., valoctocogene roxaparvovec).<\/li>\n<\/ul>\n<\/li>\n\n\n\n
            • Prognosis<\/strong>: Manageable with treatment; risk of joint damage or fatal bleeds without care.<\/li>\n\n\n\n
            • Research<\/strong>: Long-acting factor VIII products, CRISPR trials.<\/li>\n<\/ul>\n\n\n\n

              Other Single-Gene Disorders<\/h3>\n\n\n\n
                \n
              • Sickle Cell Anemia<\/strong>: Beta-globin gene mutation; causes deformed red blood cells, anemia, pain crises.<\/li>\n\n\n\n
              • Tay-Sachs Disease<\/strong>: HEXA gene mutation; leads to neurodegeneration, fatal by early childhood.<\/li>\n\n\n\n
              • Phenylketonuria (PKU)<\/strong>: PAH gene mutation; impairs phenylalanine metabolism, treatable with diet.<\/li>\n\n\n\n
              • Duchenne Muscular Dystrophy<\/strong>: DMD gene mutation; progressive muscle degeneration.<\/li>\n\n\n\n
              • Marfan Syndrome<\/strong>: FBN1 gene mutation; affects connective tissue, causing heart and skeletal issues.<\/li>\n\n\n\n
              • Fragile X Syndrome<\/strong>: FMR1 gene mutation; intellectual disability, autism-like features.<\/li>\n<\/ul>\n\n\n\n
                \n\n\n\n

                2. Chromosomal Disorders<\/h3>\n\n\n\n

                These involve structural or numerical abnormalities in chromosomes, often detected via karyotyping.<\/p>\n\n\n\n

                Key Examples<\/h3>\n\n\n\n

                Down Syndrome (Trisomy 21)<\/h4>\n\n\n\n
                  \n
                • Cause<\/strong>: Extra copy of chromosome 21 (95% due to nondisjunction during meiosis).<\/li>\n\n\n\n
                • Symptoms<\/strong>: Intellectual disability, characteristic facial features (e.g., upslanting eyes), heart defects, hypotonia.<\/li>\n\n\n\n
                • Prevalence<\/strong>: ~1 in 700 births (increases with maternal age).<\/li>\n\n\n\n
                • Diagnosis<\/strong>: Prenatal screening (e.g., ultrasound, cell-free DNA), confirmed by karyotyping.<\/li>\n\n\n\n
                • Treatment<\/strong>: Early intervention (speech, physical therapy), surgical correction of heart defects.<\/li>\n\n\n\n
                • Prognosis<\/strong>: Life expectancy ~60 years; quality of life varies.<\/li>\n\n\n\n
                • Research<\/strong>: Studies on cognitive enhancement drugs, gene silencing of extra chromosome.<\/li>\n<\/ul>\n\n\n\n

                  Turner Syndrome (Monosomy X)<\/h4>\n\n\n\n
                    \n
                  • Cause<\/strong>: Missing or partial X chromosome in females (45,X karyotype).<\/li>\n\n\n\n
                  • Symptoms<\/strong>: Short stature, infertility, heart anomalies, webbed neck.<\/li>\n\n\n\n
                  • Prevalence<\/strong>: ~1 in 2,500 female births.<\/li>\n\n\n\n
                  • Diagnosis<\/strong>: Karyotyping, often prenatal or at puberty.<\/li>\n\n\n\n
                  • Treatment<\/strong>: Growth hormone, estrogen replacement for puberty.<\/li>\n\n\n\n
                  • Prognosis<\/strong>: Normal life expectancy with management; infertility common.<\/li>\n\n\n\n
                  • Research<\/strong>: Fertility preservation techniques (e.g., oocyte cryopreservation).<\/li>\n<\/ul>\n\n\n\n

                    Klinefelter Syndrome (XXY)<\/h4>\n\n\n\n
                      \n
                    • Cause<\/strong>: Extra X chromosome in males (47,XXY).<\/li>\n\n\n\n
                    • Symptoms<\/strong>: Hypogonadism, tall stature, learning difficulties, infertility.<\/li>\n\n\n\n
                    • Prevalence<\/strong>: ~1 in 500\u20131,000 males.<\/li>\n\n\n\n
                    • Diagnosis<\/strong>: Karyotyping, often at puberty or during infertility evaluation.<\/li>\n\n\n\n
                    • Treatment<\/strong>: Testosterone therapy, educational support.<\/li>\n\n\n\n
                    • Prognosis<\/strong>: Near-normal life expectancy; fertility possible with assisted reproduction.<\/li>\n\n\n\n
                    • Research<\/strong>: Improving fertility outcomes via testicular sperm extraction.<\/li>\n<\/ul>\n\n\n\n

                      Other Chromosomal Disorders<\/h3>\n\n\n\n
                        \n
                      • Trisomy 18 (Edwards Syndrome)<\/strong>: Severe developmental delays, often fatal in infancy.<\/li>\n\n\n\n
                      • Trisomy 13 (Patau Syndrome)<\/strong>: Cleft lip\/palate, heart defects, early mortality.<\/li>\n\n\n\n
                      • Cri-du-Chat Syndrome<\/strong>: Deletion on 5p; high-pitched cry, intellectual disability.<\/li>\n\n\n\n
                      • Wolf-Hirschhorn Syndrome<\/strong>: Deletion on 4p; growth retardation, seizures.<\/li>\n<\/ul>\n\n\n\n
                        \n\n\n\n

                        3. Multifactorial Disorders<\/h3>\n\n\n\n

                        These result from multiple genetic variants interacting with environmental factors.<\/p>\n\n\n\n

                        Key Examples<\/h3>\n\n\n\n

                        Coronary Artery Disease<\/h4>\n\n\n\n
                          \n
                        • Cause<\/strong>: Polygenic risk (e.g., variants in LDLR, APOE) plus lifestyle factors (diet, smoking).<\/li>\n\n\n\n
                        • Symptoms<\/strong>: Chest pain, heart attack, heart failure.<\/li>\n\n\n\n
                        • Prevalence<\/strong>: Leading cause of death globally (~9 million deaths annually).<\/li>\n\n\n\n
                        • Diagnosis<\/strong>: ECG, stress tests, genetic risk scores.<\/li>\n\n\n\n
                        • Treatment<\/strong>: Statins, lifestyle changes, surgical interventions (e.g., stents).<\/li>\n\n\n\n
                        • Research<\/strong>: Polygenic risk scores for early prevention, novel lipid-lowering drugs.<\/li>\n<\/ul>\n\n\n\n

                          Type 2 Diabetes<\/h4>\n\n\n\n
                            \n
                          • Cause<\/strong>: Variants in TCF7L2, PPARG, combined with obesity, sedentary lifestyle.<\/li>\n\n\n\n
                          • Symptoms<\/strong>: High blood sugar, fatigue, kidney\/eye complications.<\/li>\n\n\n\n
                          • Prevalence<\/strong>: ~537 million adults globally (2021 estimate).<\/li>\n\n\n\n
                          • Diagnosis<\/strong>: Blood glucose tests, HbA1c.<\/li>\n\n\n\n
                          • Treatment<\/strong>: Metformin, insulin, diet\/exercise.<\/li>\n\n\n\n
                          • Research<\/strong>: Gene-environment interaction studies, beta-cell regeneration.<\/li>\n<\/ul>\n\n\n\n

                            Breast Cancer (BRCA1\/2 Mutations)<\/h4>\n\n\n\n
                              \n
                            • Cause<\/strong>: High-penetrance mutations in BRCA1\/BRCA2, plus environmental triggers.<\/li>\n\n\n\n
                            • Symptoms<\/strong>: Breast lumps, changes in breast shape, metastasis.<\/li>\n\n\n\n
                            • Prevalence<\/strong>: ~1 in 8 women (lifetime risk); 5\u201310% hereditary.<\/li>\n\n\n\n
                            • Diagnosis<\/strong>: Mammography, genetic testing.<\/li>\n\n\n\n
                            • Treatment<\/strong>: Surgery, chemotherapy, PARP inhibitors for BRCA mutations.<\/li>\n\n\n\n
                            • Research<\/strong>: Preventive gene therapies, improved screening algorithms.<\/li>\n<\/ul>\n\n\n\n

                              Other Multifactorial Disorders<\/h3>\n\n\n\n
                                \n
                              • Hypertension<\/strong>: Genetic variants (e.g., AGT) plus diet, stress.<\/li>\n\n\n\n
                              • Alzheimer\u2019s Disease<\/strong>: APOE4 variant, aging, environmental factors.<\/li>\n\n\n\n
                              • Asthma<\/strong>: Multiple genes, allergens, pollution.<\/li>\n\n\n\n
                              • Rheumatoid Arthritis<\/strong>: HLA genes, immune triggers.<\/li>\n<\/ul>\n\n\n\n
                                \n\n\n\n

                                4. Mitochondrial Disorders<\/h3>\n\n\n\n

                                These arise from mutations in mitochondrial DNA (maternally inherited) or nuclear genes affecting mitochondria.<\/p>\n\n\n\n

                                Key Examples<\/h3>\n\n\n\n

                                MELAS Syndrome<\/h4>\n\n\n\n
                                  \n
                                • Cause<\/strong>: Mutations in MT-TL1 or other mitochondrial genes, impairing energy production.<\/li>\n\n\n\n
                                • Symptoms<\/strong>: Stroke-like episodes, muscle weakness, lactic acidosis, seizures.<\/li>\n\n\n\n
                                • Prevalence<\/strong>: Rare (~1 in 4,000).<\/li>\n\n\n\n
                                • Diagnosis<\/strong>: Muscle biopsy, genetic testing.<\/li>\n\n\n\n
                                • Treatment<\/strong>: Symptomatic (e.g., coenzyme Q10, anticonvulsants).<\/li>\n\n\n\n
                                • Prognosis<\/strong>: Progressive; varies by mutation severity.<\/li>\n\n\n\n
                                • Research<\/strong>: Mitochondrial replacement therapy, antioxidant therapies.<\/li>\n<\/ul>\n\n\n\n

                                  Leber\u2019s Hereditary Optic Neuropathy (LHON)<\/h4>\n\n\n\n
                                    \n
                                  • Cause<\/strong>: Mutations in MT-ND1, MT-ND4, or MT-ND6 genes, affecting optic nerve.<\/li>\n\n\n\n
                                  • Symptoms<\/strong>: Rapid vision loss, usually in young adults.<\/li>\n\n\n\n
                                  • Prevalence<\/strong>: ~1 in 30,000\u201350,000.<\/li>\n\n\n\n
                                  • Diagnosis<\/strong>: Genetic testing, ophthalmologic exams.<\/li>\n\n\n\n
                                  • Treatment<\/strong>: Idebenone (antioxidant), supportive care.<\/li>\n\n\n\n
                                  • Prognosis<\/strong>: Permanent vision loss; some spontaneous recovery.<\/li>\n\n\n\n
                                  • Research<\/strong>: Gene therapy targeting optic nerve rescue.<\/li>\n<\/ul>\n\n\n\n

                                    Other Mitochondrial Disorders<\/h3>\n\n\n\n